In Vitro Diagnostics And IVD Quality Control Industry Data Book - In Vitro Diagnostics & IVD Quality Control Market Size, Share, Trends Analysis, And Segment Forecasts, 2022 - 2030

Chapter 1. Methodology and Scope

• 1.1 Market Segmentation
• 1.1.1 Estimates And Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
• 1.3.1 Purchased Database
• 1.3.2 GVR’s Internal Database
• 1.3.3 Secondary Sources
• 1.3.4 Primary Research
• 1.3.5 Details Of Primary Research
• 1.4 Information Or Data Analysis
• 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
• 1.6.1 Commodity Flow Analysis
• 1.6.1.1 Approach 1: Commodity Flow Approach
• 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
• 1.7 Global Market: CAGR Calculation
• 1.8 Research Assumptions
• 1.9 List of Secondary Sources
• 1.10 List of Primary Sources
• 1.11 Objectives
• 1.11.1 Objective 1
• 1.11.2 Objective 2
• 1.12 List Of Abbreviations

Chapter 2. Market Definitions

• 2.1 Definitions

Chapter 3. Executive Summary

• 3.1 Market Summary

Chapter 4. Global IVD Market and IVD Quality Control Variables, Trends, & Scope

• 4.1 IVD Market Lineage Outlook
• 4.1.1 Parent Market Outlook
• 4.2 Penetration And Growth Prospect Mapping
• 4.3 Regulatory Framework
• 4.4 Market Driver Analysis
• 4.4.1 Growing Geriatric Population
• 4.4.2 Technological Advancements
• 4.4.3 Increasing Demand For Poc Facilities
• 4.4.4 Growing Prevalence Of Target Diseases, And Hospital-Acquired Infections
• 4.4.5 Outbreak Of Covid-19
• 4.5 Market Restraint Analysis
• 4.5.1 Higher Cost Of Devices
• 4.5.2 Stringent Regulatory Policies
• 4.6 Value Chain Analysis
• 4.6.1 Value Chain Analysis/Route To Market
• 4.7 Consumer Behavior Analysis
• 4.8 Major Deals and Strategic Alliances Analysis
• 4.8.1 New product launch
• 4.8.1.1 Mergers and acquisitions
• 4.8.1.2 Expansion
• 4.8.1.3 Partnerships
• 4.8.1.4 Marketing & promotions
• 4.8.1.5 Market entry strategies
• 4.8.2 Mergers And Deals
• 4.9 IVD Market Analysis Tools
• 4.9.1 Industry Analysis – Porter’s
• 4.9.2 SWOT Analysis, By Pest
• 4.10 IVD Quality Control Market Analysis Tools
• 4.10.1 Industry Analysis – Porter’s
• 4.10.2 SWOT Analysis, By Pest

Chapter 5. IVD Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)

• 5.1 In Vitro Diagnostic Market: Products Movement Analysis
• 5.2 Instruments
• 5.2.1 Instruments Market, 2018 – 2030, (USD Million, Instruments Installed In Thousands)
• 5.3 Reagents
• 5.3.1 Reagents Market, 2018 – 2030, (USD Million, Reagents Sold In Million)
• 5.4 Services
• 5.4.1 Services Market Estimates And Forecast, 2018 – 2030, (USD Million)

Chapter 6. IVD Market - Segment Analysis, by Technology, 2018 - 2030 (USD Million)

• 6.1 In Vitro Diagnostics Market: Technology Movement Analysis
• 6.2 Immunoassay
• 6.2.1 Immunoassay Market, 2018 – 2030, USD Million
• 6.2.2 Instruments
• 6.2.2.1 Instruments For Immunoassay, 2018 – 2030, (USD Million, Instruments Installed In Thousands)
• 6.2.3 Reagents
• 6.2.3.1 Reagents For Immunoassay, 2018 – 2030, (USD Million, Reagents Sold In Million)
• 6.3 Hematology
• 6.3.1 Hematology Market, 2018 – 2030, (USD Million)
• 6.3.2 Instruments
• 6.3.2.1 Instruments for hematology, 2018 – 2030, (USD Million, instruments installed in thousands)
• 6.3.3 Reagents
• 6.3.3.1 Reagents for hematology, 2018 – 2030, (USD Million, Number of reagents sold in million)
• 6.4 Clinical Chemistry
• 6.4.1 Clinical Chemistry, 2018 - 2030 (USD Million)
• 6.4.2 Instruments
• 6.4.2.1 Instruments For Clinical Chemistry, 2018 – 2030, (USD Million, Number Of Instruments Installed In Thousands)
• 6.4.3 Reagents
• 6.4.3.1 Reagents For Clinical Chemistry, 2018 – 2030, (USD Million, Number Of Reagents Sold In Million
• 6.5 Molecular Diagnostics
• 6.5.1 Molecular Diagnostics Market, 2018 – 2030, (USD Million)
• 6.5.2 Instruments
• 6.5.2.1 Instruments For Molecular Diagnostics, 2018 – 2030, (USD Million, Instruments Installed In Thousands)
• 6.5.3 Reagents
• 6.5.3.1 Reagents For Molecular Diagnostics, 2018 – 2030, (USD Million, Reagents Sold In Million)
• 6.6 Coagulation
• 6.6.1 Coagulation Market, 2018 – 2030, (USD Million)
• 6.6.2 Instruments
• 6.6.2.1 Instruments For Coagulation, 2018 – 2030, (USD Million, Number Of Instruments Installed In Thousands)
• 6.6.3 Reagents
• 6.6.3.1 Reagents For Coagulation, 2018 – 2030, (USD Million, Reagents Sold In Million)
• 6.7 Microbiology
• 6.7.1 Microbiology Market, 2018 - 2030 USD Million
• 6.7.2 Instruments
• 6.7.2.1 Instruments For Microbiology, 2018 - 2030 USD Million, Number Of Instruments Installed In Thousands
• 6.7.3 Reagents
• 6.7.3.1 Reagents For Microbiology, 2018 - 2030 USD Million, Number Of Reagents Sold In Million
• 6.8 Others
• 6.8.1 Others Market Estimates And Forecast, 2018 - 2030 USD Million
• 6.8.2 Instruments
• 6.8.2.1 Instruments for others, 2018 - 2030 USD Million, Number Of Instruments Installed In Thousands
• 6.8.3 Reagents
• 6.8.3.1 Reagents for others, 2018 - 2030 USD Million, Number Of Reagents Sold In Million

Chapter 7. IVD Market - Segment Analysis, by Application, 2018 - 2030 (USD Million)

• 7.1 In Vitro Diagnostic Market: Application Movement Analysis
• 7.2 Infectious Diseases
• 7.2.1 Infectious Diseases Market, 2018 - 2030 USD Million
• 7.3 Diabetes
• 7.3.1 Diabetes Market, 2018 - 2030 USD Million
• 7.4 Oncology
• 7.4.1 Oncology Market, 2018 - 2030 USD Million
• 7.5 Cardiology
• 7.5.1 Cardiology Market, 2018 - 2030 USD Million
• 7.6 Nephrology
• 7.6.1 Nephrology Market, 2018 - 2030 USD Million
• 7.7 Autoimmune Diseases
• 7.7.1 Autoimmune Diseases Market, 2018 - 2030 USD Million
• 7.8 Drug Testing
• 7.8.1 Drug Testing Market, 2018 - 2030 USD Million
• 7.9 Others
• 7.9.1 Others Market, 2018 - 2030 USD Million

Chapter 8. IVD Market - Segment Analysis, by End-use, 2018 - 2030 (USD Million)

• 8.1 In Vitro Diagnostic Market: End-use Movement Analysis
• 8.2 Hospitals
• 8.2.1 Hospitals Market, 2018 - 2030 USD Million
• 8.3 Laboratory
• 8.3.1 Laboratory Market, 2018 - 2030 USD Million
• 8.4 Home Care
• 8.4.1 Home Care Market, 2018 - 2030 USD Million
• 8.5 Others
• 8.5.1 Other Market, 2018 - 2030 USD Million

Chapter 9. IVD Market - Segment Analysis, by Test Location, 2018 - 2030 (USD Million)

• 9.1 In Vitro Diagnostic Market: Test Location Movement Analysis
• 9.2 Point Of Care
• 9.2.1 Point-Of-Care Market, 2018 - 2030 USD Million
• 9.3 Homecare
• 9.3.1 Homecare Market, 2018 - 2030 USD Million
• 9.4 Others
• 9.4.1 Others Market, 2018 - 2030 USD Million

Chapter 10. IVD Quality Control Market - Segment Analysis, by Services, 2018 - 2030 (USD Million)

• 10.1 In Vitro Quality Control Market: Services Movement Analysis
• 10.2 Quality Control
• 10.2.1 Quality control Market, 2018 - 2030 USD Million
• 10.2.2 Clinical Chemistry Market, 2018 - 2030 USD Million
• 10.2.3 Immunochemistry Market, 2018 - 2030 USD Million
• 10.2.4 Hematology Market, 2018 - 2030 USD Million
• 10.2.5 Molecular Diagnostics Market, 2018 - 2030 USD Million
• 10.2.6 Coagulation Market, 2018 - 2030 USD Million
• 10.2.7 Others Market, 2018 - 2030 USD Million
• 10.3 Quality Assurance
• 10.3.1 Quality Assurance Market, 2018 - 2030 USD Million
• 10.3.2 Clinical Chemistry Market, 2018 - 2030 USD Million
• 10.3.3 Immunochemistry Market, 2018 - 2030 USD Million
• 10.3.4 Hematology Market, 2018 - 2030 USD Million
• 10.3.5 Molecular Diagnostics Market, 2018 - 2030 USD Million
• 10.3.6 Coagulation Market, 2018 - 2030 USD Million
• 10.3.7 Others Market, 2018 - 2030 USD Million
• 10.4 Data Management
• 10.4.1 Data Management Market, 2018 - 2030 USD Million
• 10.4.2 Clinical Chemistry Market, 2018 - 2030 USD Million
• 10.4.3 Immunochemistry Market, 2018 - 2030 USD Million
• 10.4.4 Hematology Market, 2018 - 2030 USD Million
• 10.4.5 Molecular Diagnostics Market, 2018 - 2030 USD Million
• 10.4.6 Coagulation Market, 2018 - 2030 USD Million
• 10.4.7 Others Market, 2018 - 2030 USD Million

Chapter 11. IVD and IVD Quality Market - Segment Analysis, by Region, 2018 - 2030 (USD Million)

• 11.1 In Vitro Diagnostic and IVD Quality Control Market: Regional Movement Analysis
• 11.2 North America
• 11.2.1 North America, Swot Analysis
• 11.2.2 North America IVD & IVD Quality Market, 2018 - 2030 USD Million
• 11.2.3 U.S.
• 11.2.3.1 U.S. IVD & IVD Quality Market, 2018 - 2030 USD Million
• 11.2.4 Canada
• 11.2.4.1 Canada IVD & IVD Quality Market, 2018 - 2030 USD Million
• 11.3 Europe
• 11.3.1欧洲,Swot分析
• 11.3.2 Europe IVD & IVD Quality Market, 2018 - 2030 USD Million
• 11.3.3 U.K.
• 11.3.3.1 U.K. IVD & IVD Quality Market, 2018 - 2030 USD Million
• 11.3.4 Germany
• 11.3.4.1 Germany IVD & IVD Quality Market, 2018 - 2030 USD Million
• 11.3.5 Spain
• 11.3.5.1 Spain IVD & IVD Quality Market, 2018 - 2030 USD Million
• 11.3.6 France
• 11.3.6.1 France IVD & IVD Quality Market, 2018 - 2030 USD Million
• 11.3.7 Italy
• 11.3.7.1 Italy IVD & IVD Quality Market, 2018 - 2030 USD Million
• 11.3.8 Russia
• 11.3.8.1 Russia IVD & IVD Quality Market, 2018 - 2030 USD Million
• 11.4 Asia Pacific
• 11.4.1 Asia Pacific, Swot Analysis
• 11.4.2 Asia Pacific IVD & IVD Quality Market, 2018 - 2030 USD Million
• 11.4.3 Japan
• 11.4.3.1 Japan IVD & IVD Quality Market, 2018 - 2030 USD Million
• 11.4.4 China
• 11.4.4.1 China IVD & IVD Quality Market, 2018 - 2030 USD Million
• 11.4.5 INDIA
• 11.4.5.1 India IVD & IVD Quality Market, 2018 - 2030 USD Million
• 11.4.6 South Korea
• 11.4.6.1 South Korea IVD & IVD Quality Market, 2018 - 2030 USD Million
• 11.4.7 Singapore
• 11.4.7.1 Singapore IVD & IVD Quality Market, 2018 - 2030 USD Million
• 11.4.8 Australia
• 11.4.8.1 Australia IVD & IVD Quality Market, 2018 - 2030 USD Million
• 11.5 Latin America
• 11.5.1 Latin America, Swot Analysis
• 11.5.2 Latin America Market IVD & IVD Quality Market, 2018 - 2030 USD Million
• 11.5.3 Brazil
• 11.5.3.1 Brazil IVD & IVD Quality Market, 2018 - 2030 USD Million
• 11.5.4 Mexico
• 11.5.4.1 Mexico IVD & IVD Quality Market, 2018 - 2030 USD Million
• 11.5.5 Argentina
• 11.5.5.1 Argentina IVD & IVD Quality Market, 2018 - 2030 USD Million
• 11.6 Middle East and Africa
• 11.6.1 Middle East & Africa, Swot Analysis
• 11.6.2 Middle-East And Africa IVD & IVD Quality Market, 2018 - 2030 USD Million
• 11.6.3 South Africa
• 11.6.3.1 South Africa Market IVD & IVD Quality Market, 2018 - 2030 USD Million
• 11.6.4 United Arab Emirates
• 11.6.4.1 United Arab IVD & IVD Quality Market, 2018 - 2030 USD Million
• 11.6.5 Saudi Arabia
• 11.6.5.1 Saudi Arabia IVD & IVD Quality Market, 2018 - 2030 USD Million

Chapter 12 Competitive Analysis

• 12.1 Recent Developments & Impact Analysis, By Key Market Participants
• 12.1.1 Ansoff Matrix
• 12.1.2 Company/Competition Categorization (Key Innovators, Market Leaders, Expansion)
• 12.1.3 Innovators
• 12.2 Vendor Landscape
• 12.2.1 List Of Key Distributors And Channel Partners
• 12.2.2 Global IVD Market: Key Company Market Share Analysis, 2021
• 12.3 Mass Spectrometry
• 12.3.1 Global Clinical Mass Spectrometry Company Market Share Analysis, 2021
• 12.3.2北美临床质谱有限公司mpany Market Share Analysis, 2021
• 12.3.3 Europe Clinical Mass Spectrometry Company Market Share Analysis, 2021
• 12.3.4 Asia Pacific Clinical Mass Spectrometry Company Market Share Analysis, 2021
• 12.4 Immunoassay
• 12.4.1 Global Clinical Immunoassay Company Market Share Analysis, 2021
• 12.4.2 North America Clinical Immunoassay Company Market Share Analysis, 2021
• 12.4.3 Europe Clinical Immunoassay Company Market Share Analysis, 2021
• 12.4.4 Asia Pacific Clinical Immunoassay Company Market Share Analysis, 2021
• 12.5 PCR
• 12.5.1 Global Clinical PCR Company Market Share Analysis, 2021
• 12.5.2 North America Clinical PCR Company Market Share Analysis, 2021
• 12.5.3 Europe Clinical PCR Company Market Share Analysis, 2021
• 12.5.4 Asia Pacific Clinical PCR Company Market Share Analysis, 2020
• 12.6 Public Companies
• 12.6.1 Company Market Position Analysis
• 12.6.2 Competitive Dashboard Analysis
• 12.6.3 Strategic Framework
• 12.7 Private Companies
• 12.7.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
• 12.7.2 Regional Network Map
• 12.8 Company Profiles
• 12.8.1 ABBOTT
• 12.8.1.1 Company Overview
• 12.8.1.2 Alere, Inc.
• 12.8.1.3 Financial Performance
• 12.8.1.4 Product Benchmarking
• 12.8.1.5 Strategic Initiatives
• 12.8.2 BIOMÉRIEUX SA
• 12.8.2.1 Company Overview
• 12.8.2.2 Financial Performance
• 12.8.2.3 Product Benchmarking
• 12.8.2.4 Strategic Initiatives
• 12.8.3 BIO-RAD LABORATORIES, INC.
• 12.8.3.1 Company Overview
• 12.8.3.2 Financial Performance
• 12.8.3.3 Product Benchmarking
• 12.8.3.4 Strategic Initiatives
• 12.8.4 BECTON, DICKINSON AND COMPANY
• 12.8.4.1 Company Overview
• 12.8.4.2 Financial Performance
• 12.8.4.3 Product Benchmarking
• 12.8.4.4 Strategic Initiatives
• 12.8.5 SIEMENS HEALTHINEERS AG
• 12.8.5.1 Company Overview
• 12.8.5.2 Financial Performance
• 12.8.5.3 Product Benchmarking
• 12.8.5.4 Strategic Initiatives
• 12.8.6 QIAGEN
• 12.8.6.1 Company Overview
• 12.8.6.2 Financial Performance
• 12.8.6.3 Product Benchmarking
• 12.8.6.4 Strategic Initiatives
• 12.8.7 QUIDEL CORPORATION
• 12.8.7.1 Company Overview
• 12.8.7.2 Financial Performance
• 12.8.7.3 Product Benchmarking
• 12.8.7.4 Strategic Initiatives
• 12.8.8 F. HOFFMANN-LA ROCHE LTD.
• 12.8.8.1 Company Overview
• 12.8.8.2 Financial Performance
• 12.8.8.3 Product Benchmarking
• 12.8.8.4 Strategic Initiatives
• 12.8.9 SYSMEX CORPORATION
• 12.8.9.1 Company Overview
• 12.8.9.2 Financial Performance
• 12.8.9.3 Product Benchmarking
• 12.8.9.4 Strategic Initiatives
• 12.8.10 CHARLES RIVER LABORATORIES
• 12.8.10.1 Company Overview
• 12.8.10.2 Financial Performance
• 12.8.10.3 Product Benchmarking
• 12.8.10.4 Strategic Initiatives
• 12.8.11 QUEST DIAGNOSTICS
• 12.8.11.1公司Overview
• 12.8.11.2 Financial Performance
• 12.8.11.3 Product Benchmarking
• 12.8.11.4 Strategic Initiatives
• 12.8.12 AGILENT TECHNOLOGIES, INC.
• 12.8.12.1 Company Overview
• 12.8.12.2 Financial Performance
• 12.8.12.3 Product Benchmarking
• 12.8.12.4 Strategic Initiatives
• 12.8.13 DANAHER CORPORATION
• 12.8.13.1 Company Overview
• 12.8.13.2 Cepheid
• 12.8.13.3 Beckman Coulter
• 12.8.13.4 Leica Biosystems
• 12.8.13.5 Financial Performance
• 12.8.13.6 Product Benchmarking
• 12.8.13.7 Strategic Initiatives
• 12.8.13.8 Strategic Initiatives- Beckman Coulter, Inc.
• 12.8.13.9 Strategic Initiatives- Leica Biosystems
• 12.8.14 Bio-Rad Laboratories, Inc.
• 12.8.14.1 Company Overview
• 12.8.14.2 Financial Performance
• 12.8.14.3 Product Benchmarking
• 12.8.14.4 Strategic Initiatives
• 12.8.15 Thermo Fisher Scientific, Inc.
• 12.8.15.1 Company Overview
• 12.8.15.2 Financial Performance
• 12.8.15.3 Product Benchmarking
• 12.8.15.4 Strategic Initiatives
• 12.8.16 Sero AS.
• 12.8.16.1 Company Overview
• 12.8.16.2 Financial Performance
• 12.8.16.3 Product Benchmarking
• 12.8.16.4 Strategic Initiatives
• 12.8.17 Sun Diagnostics, LLC
• 12.8.17.1 Company Overview
• 12.8.17.2 Financial Performance
• 12.8.17.3 Product Benchmarking
• 12.8.17.4 Strategic Initiatives
• 12.8.18 Ortho Clinical Diagnostics, Inc.
• 12.8.18.1 Company Overview
• 12.8.18.2 Financial Performance
• 12.8.18.3 Product Benchmarking
• 12.8.18.4 Strategic Initiatives
• 12.8.19 Randox Laboratories Ltd
• 12.8.19.1 Company Overview
• 12.8.19.2 Financial Performance
• 12.8.19.3 Product Benchmarking
• 12.8.19.4 Strategic Initiatives
• 12.8.20 Helena Laboratories Corporation
• 12.8.20.1 Company Overview
• 12.8.20.2 Financial Performance
• 12.8.20.3 Product Benchmarking
• 12.8.20.4 Strategic Initiatives
• 12.8.21 SeraCare Life Sciences, Inc.
• 12.8.21.1 Company Overview
• 12.8.21.2 Financial Performance
• 12.8.21.3 Product Benchmarking
• 12.8.21.4 Strategic Initiatives
• 12.8.22 Technopath Clinical Diagnostics
• 12.8.22.1 Company Overview
• 12.8.22.2 Financial Performance
• 12.8.22.3 Product Benchmarking
• 12.8.22.4 Strategic Initiatives